{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T19:08:16Z","timestamp":1772305696629,"version":"3.50.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,12]],"date-time":"2018-07-12T00:00:00Z","timestamp":1531353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,7,12]],"date-time":"2018-07-12T00:00:00Z","timestamp":1531353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"U.S. Department of Health &amp; Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA035499"],"award-info":[{"award-number":["DA035499"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"U.S. Department of Health &amp; Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA035499"],"award-info":[{"award-number":["DA035499"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"U.S. Department of Health &amp; Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA035499"],"award-info":[{"award-number":["DA035499"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"U.S. Department of Health &amp; Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA035499"],"award-info":[{"award-number":["DA035499"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cerebrovascular damage caused by either exposure to stress or the widely abused drug, methamphetamine (Meth) is known but stress and drug abuse frequently occur in tandem that may impact their individual cerebrovascular effects. This study examined their co-morbid cerebrovascular effects during abstinence from self-administered Meth after the exposure to chronic unpredictable stress (CUS). Exposure to CUS prior to unrestricted Meth self-administration had no effect on Meth intake in rats; however, the pro-inflammatory mediator cyclooxygenase-2 (COX-2) and the breakdown of cell-matrix adhesion protein \u03b2-dystroglycan in isolated cerebral cortical capillaries were increased after 3 days of abstinence and persisted for 7 days. These changes preceded decreases in occludin, a key structural protein component of the blood-brain barrier. The decrease in occludin was blocked by the COX-2 specific inhibitor nimesulide treatment during abstinence from Meth. The changes in COX-2, \u03b2-dystroglycan, and occludin were only evident following the serial exposure to stress and Meth but not after either one alone. These results suggest that stress and voluntary Meth intake can synergize and disrupt cerebrovasculature in a time-dependent manner during abstinence from chronic stress and Meth. Furthermore, COX-2 inhibition may be a viable pharmacological intervention to block vascular changes after Meth exposure.<\/jats:p>","DOI":"10.1038\/s41598-018-28970-1","type":"journal-article","created":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T11:36:13Z","timestamp":1530876973000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cerebrovascular Injury After Serial Exposure to Chronic Stress and Abstinence from Methamphetamine Self-Administration"],"prefix":"10.1038","volume":"8","author":[{"given":"Reka","family":"Natarajan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen M.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Harless","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan K.","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,12]]},"reference":[{"key":"28970_CR1","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1365-2990.2008.01005.x","volume":"35","author":"HB Stolp","year":"2009","unstructured":"Stolp, H. B. & Dziegielewska, K. M. Review: Role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases. Neuropathology and applied neurobiology 35, 132\u2013146, https:\/\/doi.org\/10.1111\/j.1365-2990.2008.01005.x (2009).","journal-title":"Neuropathology and applied neurobiology"},{"key":"28970_CR2","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1177\/0271678X15616978","volume":"36","author":"RK Sajja","year":"2016","unstructured":"Sajja, R. K., Rahman, S. & Cucullo, L. Drugs of abuse and blood-brain barrier endothelial dysfunction: A focus on the role of oxidative stress. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism 36, 539\u2013554, https:\/\/doi.org\/10.1177\/0271678x15616978 (2016).","journal-title":"Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism"},{"key":"28970_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-10-142","volume":"10","author":"S Najjar","year":"2013","unstructured":"Najjar, S., Pearlman, D. M., Devinsky, O., Najjar, A. & Zagzag, D. Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence. Journal of neuroinflammation 10, 142, https:\/\/doi.org\/10.1186\/1742-2094-10-142 (2013).","journal-title":"Journal of neuroinflammation"},{"key":"28970_CR4","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1046\/j.1365-2362.2002.00994.x","volume":"32","author":"M Fiala","year":"2002","unstructured":"Fiala, M. et al. Cyclooxygenase-2-positive macrophages infiltrate the Alzheimer\u2019s disease brain and damage the blood-brain barrier. European journal of clinical investigation 32, 360\u2013371 (2002).","journal-title":"European journal of clinical investigation"},{"key":"28970_CR5","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1111\/j.1460-9568.2007.05741.x","volume":"26","author":"EA Kiyatkin","year":"2007","unstructured":"Kiyatkin, E. A., Brown, P. L. & Sharma, H. S. Brain edema and breakdown of the blood-brain barrier during methamphetamine intoxication: critical role of brain hyperthermia. Eur J Neurosci 26, 1242\u20131253, https:\/\/doi.org\/10.1111\/j.1460-9568.2007.05741.x (2007).","journal-title":"Eur J Neurosci"},{"key":"28970_CR6","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1097\/WNR.0b013e32834d0bc8","volume":"22","author":"SM Kousik","year":"2011","unstructured":"Kousik, S. M., Graves, S. M., Napier, T. C., Zhao, C. & Carvey, P. M. Methamphetamine-induced vascular changes lead to striatal hypoxia and dopamine reduction. Neuroreport 22, 923\u2013928, https:\/\/doi.org\/10.1097\/WNR.0b013e32834d0bc8 (2011).","journal-title":"Neuroreport"},{"key":"28970_CR7","doi-asserted-by":"publisher","first-page":"172","DOI":"10.4161\/23328940.2014.982049","volume":"1","author":"JF Bowyer","year":"2014","unstructured":"Bowyer, J. F. & Hanig, J. P. Amphetamine- and methamphetamine-induced hyperthermia: Implications of the effects produced in brain vasculature and peripheral organs to forebrain neurotoxicity. Temperature (Austin, Tex.) 1, 172\u2013182, https:\/\/doi.org\/10.4161\/23328940.2014.982049 (2014).","journal-title":"Temperature (Austin, Tex.)"},{"key":"28970_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-11-34","volume":"11","author":"RM de Pablos","year":"2014","unstructured":"de Pablos, R. M. et al. Chronic stress enhances microglia activation and exacerbates death of nigral dopaminergic neurons under conditions of inflammation. Journal of neuroinflammation 11, 34, https:\/\/doi.org\/10.1186\/1742-2094-11-34 (2014).","journal-title":"Journal of neuroinflammation"},{"key":"28970_CR9","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000470813","volume":"31","author":"K Rea","year":"2017","unstructured":"Rea, K., Dinan, T. G. & Cryan, J. F. The Brain-Gut Axis Contributes to Neuroprogression in Stress-Related Disorders. Modern trends in pharmacopsychiatry 31, 152\u2013161, https:\/\/doi.org\/10.1159\/000470813 (2017).","journal-title":"Modern trends in pharmacopsychiatry"},{"key":"28970_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ynstr.2016.03.001","volume":"4","author":"K Rea","year":"2016","unstructured":"Rea, K., Dinan, T. G. & Cryan, J. F. The microbiome: A key regulator of stress and neuroinflammation. Neurobiology of stress 4, 23\u201333, https:\/\/doi.org\/10.1016\/j.ynstr.2016.03.001 (2016).","journal-title":"Neurobiology of stress"},{"key":"28970_CR11","doi-asserted-by":"publisher","unstructured":"Fox, H. C., D\u2019sa, C. & Kimmerling, A. Immune system inflammation in cocaine dependent individuals: implications for medications development. Human \u2026, https:\/\/doi.org\/10.1002\/hup.1251 (2012).","DOI":"10.1002\/hup.1251"},{"key":"28970_CR12","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/jnc.14143","volume":"143","author":"JF Bowyer","year":"2017","unstructured":"Bowyer, J. F. et al. Corticosterone and exogenous glucose alter blood glucose levels, neurotoxicity, and vascular toxicity produced by methamphetamine. J Neurochem 143, 198\u2013213, https:\/\/doi.org\/10.1111\/jnc.14143 (2017).","journal-title":"J Neurochem"},{"key":"28970_CR13","doi-asserted-by":"crossref","unstructured":"Northrop, N. A. & Yamamoto, B. K. Persistent neuroinflammatory effects of serial exposure to stress and methamphetamine on the blood-brain barrier. Journal of Neuroimmune Pharmacology (2012).","DOI":"10.1007\/s11481-012-9391-y"},{"key":"28970_CR14","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1210\/en.2007-0482","volume":"149","author":"B Garcia-Bueno","year":"2008","unstructured":"Garcia-Bueno, B., Madrigal, J. L., Perez-Nievas, B. G. & Leza, J. C. Stress mediators regulate brain prostaglandin synthesis and peroxisome proliferator-activated receptor-gamma activation after stress in rats. Endocrinology 149, 1969\u20131978, https:\/\/doi.org\/10.1210\/en.2007-0482 (2008).","journal-title":"Endocrinology"},{"key":"28970_CR15","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1038\/sj.npp.1300187","volume":"28","author":"JL Madrigal","year":"2003","unstructured":"Madrigal, J. L. et al. Induction of cyclooxygenase-2 accounts for restraint stress-induced oxidative status in rat brain. Neuropsychopharmacology 28, 1579\u20131588, https:\/\/doi.org\/10.1038\/sj.npp.1300187 (2003).","journal-title":"Neuropsychopharmacology"},{"key":"28970_CR16","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.neuropharm.2013.04.040","volume":"72","author":"NA Northrop","year":"2013","unstructured":"Northrop, N. A. & Yamamoto, B. K. Cyclooxygenase activity contributes to the monoaminergic damage caused by serial exposure to stress and methamphetamine. Neuropharmacology 72, 96\u2013105, https:\/\/doi.org\/10.1016\/j.neuropharm.2013.04.040 (2013).","journal-title":"Neuropharmacology"},{"key":"28970_CR17","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1111\/j.1360-0443.2009.02564.x","volume":"104","author":"CC Cruickshank","year":"2009","unstructured":"Cruickshank, C. C. & Dyer, K. R. A review of the clinical pharmacology of methamphetamine. Addiction 104, 1085\u20131099, https:\/\/doi.org\/10.1111\/j.1360-0443.2009.02564.x (2009).","journal-title":"Addiction"},{"key":"28970_CR18","doi-asserted-by":"crossref","unstructured":"Northrop, N. A. & Yamamoto, B. K. In Neuroinflammation and Neurodegeneration (eds Phillip K. Peterson & Michal Toborek) 443\u2013462 (Springer New York, 2014).","DOI":"10.1007\/978-1-4939-1071-7_21"},{"key":"28970_CR19","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/syn.20324","volume":"60","author":"JF Bowyer","year":"2006","unstructured":"Bowyer, J. F. & Ali, S. High doses of methamphetamine that cause disruption of the blood-brain barrier in limbic regions produce extensive neuronal degeneration in mouse hippocampus. Synapse 60, 521\u2013532, https:\/\/doi.org\/10.1002\/syn.20324 (2006).","journal-title":"Synapse"},{"key":"28970_CR20","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.neuropharm.2011.07.007","volume":"62","author":"ML Logrip","year":"2012","unstructured":"Logrip, M. L., Zorrilla, E. P. & Koob, G. F. Stress modulation of drug self-administration: implications for addiction comorbidity with post-traumatic stress disorder. Neuropharmacology 62, 552\u2013564, https:\/\/doi.org\/10.1016\/j.neuropharm.2011.07.007 (2012).","journal-title":"Neuropharmacology"},{"key":"28970_CR21","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.neuroscience.2003.12.007","volume":"124","author":"L Matuszewich","year":"2004","unstructured":"Matuszewich, L. & Yamamoto, B. K. Chronic stress augments the long-term and acute effects of methamphetamine. Neuroscience 124, 637\u2013646, https:\/\/doi.org\/10.1016\/j.neuroscience.2003.12.007 (2004).","journal-title":"Neuroscience"},{"key":"28970_CR22","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/j.1460-9568.2007.05688.x","volume":"26","author":"DA Tata","year":"2007","unstructured":"Tata, D. A., Raudensky, J. & Yamamoto, B. K. Augmentation of methamphetamine-induced toxicity in the rat striatum by unpredictable stress: contribution of enhanced hyperthermia. Eur J Neurosci 26, 739\u2013748, https:\/\/doi.org\/10.1111\/j.1460-9568.2007.05688.x (2007).","journal-title":"Eur J Neurosci"},{"key":"28970_CR23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/syn.20497","volume":"62","author":"DA Tata","year":"2008","unstructured":"Tata, D. A. & Yamamoto, B. K. Chronic stress enhances methamphetamine-induced extracellular glutamate and excitotoxicity in the rat striatum. Synapse 62, 325\u2013336, https:\/\/doi.org\/10.1002\/syn.20497 (2008).","journal-title":"Synapse"},{"key":"28970_CR24","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/j.1471-4159.2012.07864.x","volume":"122","author":"KA Kelly","year":"2012","unstructured":"Kelly, K. A., Miller, D. B., Bowyer, J. F. & O\u2019Callaghan, J. P. Chronic exposure to corticosterone enhances the neuroinflammatory and neurotoxic responses to methamphetamine. J Neurochem 122, 995\u20131009, https:\/\/doi.org\/10.1111\/j.1471-4159.2012.07864.x (2012).","journal-title":"J Neurochem"},{"key":"28970_CR25","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0002-9343(98)00091-6","volume":"104","author":"B Cryer","year":"1998","unstructured":"Cryer, B. & Feldman, M. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Am J Med 104, 413\u2013421 (1998).","journal-title":"Am J Med"},{"key":"28970_CR26","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1096\/fasebj.12.12.1063","volume":"12","author":"RN Dubois","year":"1998","unstructured":"Dubois, R. N. et al. Cyclooxygenase in biology and disease. Faseb j 12, 1063\u20131073 (1998).","journal-title":"Faseb j"},{"key":"28970_CR27","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/j.1471-4159.2006.03926.x","volume":"98","author":"SH Choi","year":"2006","unstructured":"Choi, S. H., Langenbach, R. & Bosetti, F. Cyclooxygenase-1 and \u22122 enzymes differentially regulate the brain upstream NF-kappa B pathway and downstream enzymes involved in prostaglandin biosynthesis. J Neurochem 98, 801\u2013811, https:\/\/doi.org\/10.1111\/j.1471-4159.2006.03926.x (2006).","journal-title":"J Neurochem"},{"key":"28970_CR28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.pbb.2013.08.005","volume":"111","author":"EM Cornett","year":"2013","unstructured":"Cornett, E. M. & Goeders, N. E. 96-hour methamphetamine self-administration in male and female rats: a novel model of human methamphetamine addiction. Pharmacol Biochem Behav 111, 51\u201357, https:\/\/doi.org\/10.1016\/j.pbb.2013.08.005 (2013).","journal-title":"Pharmacol Biochem Behav"},{"key":"28970_CR29","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s002130050456","volume":"134","author":"P Willner","year":"1997","unstructured":"Willner, P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology 134, 319\u2013329, https:\/\/doi.org\/10.1007\/s002130050456 (1997).","journal-title":"Psychopharmacology"},{"key":"28970_CR30","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S0149-7634(05)80194-0","volume":"16","author":"P Willner","year":"1992","unstructured":"Willner, P., Muscat, R. & Papp, M. Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci Biobehav Rev 16, 525\u2013534 (1992).","journal-title":"Neurosci Biobehav Rev"},{"key":"28970_CR31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/0006-8993(95)00788-R","volume":"698","author":"M Haney","year":"1995","unstructured":"Haney, M., Maccari, S., Le Moal, M., Simon, H. & Piazza, P. V. Social stress increases the acquisition of cocaine self-administration in male and female rats. Brain Res 698, 46\u201352 (1995).","journal-title":"Brain Res"},{"key":"28970_CR32","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/0006-8993(90)90431-A","volume":"514","author":"PV Piazza","year":"1990","unstructured":"Piazza, P. V., Deminiere, J. M., le Moal, M. & Simon, H. Stress- and pharmacologically-induced behavioral sensitization increases vulnerability to acquisition of amphetamine self-administration. Brain Res 514, 22\u201326 (1990).","journal-title":"Brain Res"},{"key":"28970_CR33","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1007\/s00213-014-3501-x","volume":"231","author":"G Yu","year":"2014","unstructured":"Yu, G., Chen, H. & Sharp, B. M. Amplified reacquisition of nicotine self-administration in rats by repeated stress during abstinence. Psychopharmacology (Berl) 231, 3189\u20133195, https:\/\/doi.org\/10.1007\/s00213-014-3501-x (2014).","journal-title":"Psychopharmacology (Berl)"},{"key":"28970_CR34","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1124\/jpet.114.217802","volume":"351","author":"SM Kousik","year":"2014","unstructured":"Kousik, S. M., Napier, T. C., Ross, R. D., Sumner, D. R. & Carvey, P. M. Dopamine receptors and the persistent neurovascular dysregulation induced by methamphetamine self-administration in rats. J Pharmacol Exp Ther 351, 432\u2013439, https:\/\/doi.org\/10.1124\/jpet.114.217802 (2014).","journal-title":"J Pharmacol Exp Ther"},{"key":"28970_CR35","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1124\/jpet.111.188433","volume":"340","author":"LM McFadden","year":"2012","unstructured":"McFadden, L. M. et al. Methamphetamine self-administration causes persistent striatal dopaminergic alterations and mitigates the deficits caused by a subsequent methamphetamine exposure. J Pharmacol Exp Ther 340, 295\u2013303, https:\/\/doi.org\/10.1124\/jpet.111.188433 (2012).","journal-title":"J Pharmacol Exp Ther"},{"key":"28970_CR36","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/npp.2009.110","volume":"35","author":"GF Koob","year":"2010","unstructured":"Koob, G. F. & Volkow, N. D. Neurocircuitry of addiction. Neuropsychopharmacology 35, 217\u2013238, https:\/\/doi.org\/10.1038\/npp.2009.110 (2010).","journal-title":"Neuropsychopharmacology"},{"key":"28970_CR37","doi-asserted-by":"publisher","first-page":"6214","DOI":"10.1523\/JNEUROSCI.3781-16.2017","volume":"37","author":"R Natarajan","year":"2017","unstructured":"Natarajan, R., Forrester, L., Chiaia, N. L. & Yamamoto, B. K. Chronic-Stress-Induced Behavioral Changes Associated with Subregion-Selective Serotonin Cell Death in the Dorsal Raphe. J Neurosci 37, 6214\u20136223, https:\/\/doi.org\/10.1523\/jneurosci.3781-16.2017 (2017).","journal-title":"J Neurosci"},{"key":"28970_CR38","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3389\/fnins.2015.00069","volume":"9","author":"NA Northrop","year":"2015","unstructured":"Northrop, N. A. & Yamamoto, B. K. Methamphetamine effects on blood-brain barrier structure and function. Frontiers in Neuroscience 9, 69, https:\/\/doi.org\/10.3389\/fnins.2015.00069 (2015).","journal-title":"Frontiers in Neuroscience"},{"key":"28970_CR39","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neuropharm.2016.03.018","volume":"107","author":"NA Northrop","year":"2016","unstructured":"Northrop, N. A., Halpin, L. E. & Yamamoto, B. K. Peripheral ammonia and blood brain barrier structure and function after methamphetamine. Neuropharmacology 107, 18\u201326, https:\/\/doi.org\/10.1016\/j.neuropharm.2016.03.018 (2016).","journal-title":"Neuropharmacology"},{"key":"28970_CR40","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1111\/j.1471-4159.2006.04280.x","volume":"100","author":"E Candelario-Jalil","year":"2007","unstructured":"Candelario-Jalil, E., Gonzalez-Falcon, A., Garcia-Cabrera, M., Leon, O. S. & Fiebich, B. L. Post-ischaemic treatment with the cyclooxygenase-2 inhibitor nimesulide reduces blood-brain barrier disruption and leukocyte infiltration following transient focal cerebral ischaemia in rats. J Neurochem 100, 1108\u20131120, https:\/\/doi.org\/10.1111\/j.1471-4159.2006.04280.x (2007).","journal-title":"J Neurochem"},{"key":"28970_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-2-3","volume":"2","author":"E Candelario-Jalil","year":"2005","unstructured":"Candelario-Jalil, E. et al. Effects of the cyclooxygenase-2 inhibitor nimesulide on cerebral infarction and neurological deficits induced by permanent middle cerebral artery occlusion in the rat. Journal of neuroinflammation 2, 3, https:\/\/doi.org\/10.1186\/1742-2094-2-3 (2005).","journal-title":"Journal of neuroinflammation"},{"key":"28970_CR42","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1203\/PDR.0b013e3180db2902","volume":"62","author":"RW Hickey","year":"2007","unstructured":"Hickey, R. W. et al. Cyclooxygenase-2 activity following traumatic brain injury in the developing rat. Pediatric research 62, 271\u2013276, https:\/\/doi.org\/10.1203\/PDR.0b013e3180db2902 (2007).","journal-title":"Pediatric research"},{"key":"28970_CR43","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.bbi.2006.08.004","volume":"21","author":"VH Perry","year":"2007","unstructured":"Perry, V. H. Stress primes microglia to the presence of systemic inflammation: implications for environmental influences on the brain. Brain, behavior, and immunity 21, 45\u201346, https:\/\/doi.org\/10.1016\/j.bbi.2006.08.004 (2007).","journal-title":"Brain, behavior, and immunity"},{"key":"28970_CR44","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1006\/brbi.2001.0638","volume":"16","author":"JD Johnson","year":"2002","unstructured":"Johnson, J. D. et al. Prior stressor exposure sensitizes LPS-induced cytokine production. Brain, behavior, and immunity 16, 461\u2013476 (2002).","journal-title":"Brain, behavior, and immunity"},{"key":"28970_CR45","doi-asserted-by":"publisher","first-page":"5756","DOI":"10.1523\/JNEUROSCI.1179-08.2008","volume":"28","author":"Y Sekine","year":"2008","unstructured":"Sekine, Y. et al. Methamphetamine causes microglial activation in the brains of human abusers. J Neurosci 28, 5756\u20135761, https:\/\/doi.org\/10.1523\/jneurosci.1179-08.2008 (2008).","journal-title":"J Neurosci"},{"key":"28970_CR46","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1002\/dneu.20954","volume":"71","author":"KM Baeten","year":"2011","unstructured":"Baeten, K. M. & Akassoglou, K. Extracellular matrix and matrix receptors in blood-brain barrier formation and stroke. Developmental neurobiology 71, 1018\u20131039, https:\/\/doi.org\/10.1002\/dneu.20954 (2011).","journal-title":"Developmental neurobiology"},{"key":"28970_CR47","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.brainres.2010.02.054","volume":"1326","author":"M Lischper","year":"2010","unstructured":"Lischper, M., Beuck, S., Thanabalasundaram, G., Pieper, C. & Galla, H. J. Metalloproteinase mediated occludin cleavage in the cerebral microcapillary endothelium under pathological conditions. Brain Res 1326, 114\u2013127, https:\/\/doi.org\/10.1016\/j.brainres.2010.02.054 (2010).","journal-title":"Brain Res"},{"key":"28970_CR48","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1074\/jbc.M506846200","volume":"281","author":"S Pavlovic","year":"2006","unstructured":"Pavlovic, S. et al. Targeting prostaglandin E2 receptors as an alternative strategy to block cyclooxygenase-2-dependent extracellular matrix-induced matrix metalloproteinase-9 expression by macrophages. The Journal of biological chemistry 281, 3321\u20133328, https:\/\/doi.org\/10.1074\/jbc.M506846200 (2006).","journal-title":"The Journal of biological chemistry"},{"key":"28970_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/srep17956","volume":"5","author":"JC Frankowski","year":"2015","unstructured":"Frankowski, J. C. et al. Detrimental role of the EP1 prostanoid receptor in blood-brain barrier damage following experimental ischemic stroke. Scientific reports 5, 17956, https:\/\/doi.org\/10.1038\/srep17956 (2015).","journal-title":"Scientific reports"},{"key":"28970_CR50","doi-asserted-by":"publisher","first-page":"521","DOI":"10.2353\/ajpath.2008.070076","volume":"172","author":"M Yamamoto","year":"2008","unstructured":"Yamamoto, M. et al. Phosphorylation of claudin-5 and occludin by rho kinase in brain endothelial cells. Am J Pathol 172, 521\u2013533, https:\/\/doi.org\/10.2353\/ajpath.2008.070076 (2008).","journal-title":"Am J Pathol"},{"key":"28970_CR51","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0149-7634(81)90005-1","volume":"5","author":"R Katz","year":"1981","unstructured":"Katz, R., Roth, K. & Carroll, B. Acute and chronic stress effects on open field activity in the rat: implications for a model of depression. Neuroscience and biobehavioral reviews 5, 247\u2013251, https:\/\/doi.org\/10.1016\/0149-7634(81)90005-1 (1981).","journal-title":"Neuroscience and biobehavioral reviews"},{"key":"28970_CR52","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1111\/ejn.12628","volume":"40","author":"SM Kousik","year":"2014","unstructured":"Kousik, S. M., Carvey, P. M. & Napier, T. C. Methamphetamine self-administration results in persistent dopaminergic pathology: implications for Parkinson\u2019s disease risk and reward-seeking. Eur J Neurosci 40, 2707\u20132714, https:\/\/doi.org\/10.1111\/ejn.12628 (2014).","journal-title":"Eur J Neurosci"},{"key":"28970_CR53","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1046\/j.1365-2885.2001.00303.x","volume":"24","author":"PL Toutain","year":"2001","unstructured":"Toutain, P. L., Cester, C. C., Haak, T. & Metge, S. Pharmacokinetic profile and in vitro selective cyclooxygenase-2 inhibition by nimesulide in the dog. Journal of veterinary pharmacology and therapeutics 24, 35\u201342 (2001).","journal-title":"Journal of veterinary pharmacology and therapeutics"},{"key":"28970_CR54","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11481-012-9420-x","volume":"8","author":"JH Anneken","year":"2013","unstructured":"Anneken, J. H., Cunningham, J. I., Collins, S. A., Yamamoto, B. K. & Gudelsky, G. A. MDMA increases glutamate release and reduces parvalbumin-positive GABAergic cells in the dorsal hippocampus of the rat: role of cyclooxygenase. J Neuroimmune Pharmacol 8, 58\u201365, https:\/\/doi.org\/10.1007\/s11481-012-9420-x (2013).","journal-title":"J Neuroimmune Pharmacol"},{"key":"28970_CR55","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3109\/01480540903390018","volume":"33","author":"AM Jha","year":"2010","unstructured":"Jha, A. M. & Abha. Assessment of cytotoxic and clastogenic effects of nimesulide: an NSAID drug in somatic cells of BALB\/c mice in vivo. Drug and chemical toxicology 33, 204\u2013208, https:\/\/doi.org\/10.3109\/01480540903390018 (2010).","journal-title":"Drug and chemical toxicology"},{"key":"28970_CR56","first-page":"17","volume":"24","author":"Y Taniguchi","year":"1998","unstructured":"Taniguchi, Y. et al. Inhibition by nimesulide of prostaglandin production in rat macrophages. Drugs under experimental and clinical research 24, 17\u201327 (1998).","journal-title":"Drugs under experimental and clinical research"},{"key":"28970_CR57","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0014-2999(97)00183-0","volume":"330","author":"Y Taniguchi","year":"1997","unstructured":"Taniguchi, Y. et al. Inhibition of brain cyclooxygenase-2 activity and the antipyretic action of nimesulide. Eur J Pharmacol 330, 221\u2013229 (1997).","journal-title":"Eur J Pharmacol"},{"key":"28970_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2006.11.089","volume":"1134","author":"S Yousif","year":"2007","unstructured":"Yousif, S., Marie-Claire, C., Roux, F., Scherrmann, J. M. & Decleves, X. Expression of drug transporters at the blood-brain barrier using an optimized isolated rat brain microvessel strategy. Brain Res 1134, 1\u201311, https:\/\/doi.org\/10.1016\/j.brainres.2006.11.089 (2007).","journal-title":"Brain Res"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28970-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28970-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28970-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T07:16:27Z","timestamp":1671606987000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28970-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,12]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["28970"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-28970-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,12]]},"assertion":[{"value":"30 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"10558"}}